Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;38(5):350-358.
doi: 10.1089/AID.2021.0138. Epub 2021 Nov 25.

HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021

Fatima Laher  1 , Simone I Richardson  1   2 , Philip Smith  3 , Patrick S Sullivan  4 , Andrea G Abrahams  5 , Osaretin E Asowata  6 , Patrick Bitangumutwenzi  7 , Smritee Dabee  8 , Annabell Dollah  9 , Natalia Fernandez  10 , Robert K Langat  11 , Devi Leena Bose  12 , Udom Likhitwonnawut  13 , Ranajoy Mullick  12 , Rachel S Resop  14 , Jyoti Sutar  15 , Ashaki Nzingha Thompson-Hall  16 , Michael W Traeger  17 , Marina Tuyishime  18 , Jacque Wambui  19 , Linda-Gail Bekker  3 , Pontiano Kaleebu  20 , Sheena McCormack  21 , David H O'Connor  22 , Mitchell Warren  23 , Tamara Torri  24 , Bargavi Thyagarajan  24
Affiliations

HIV Prevention in a Time of COVID-19: A Report from the HIVR4P // Virtual Conference 2021

Fatima Laher et al. AIDS Res Hum Retroviruses. 2022 May.

Abstract

The HIV Research for Prevention (HIVR4P) conference catalyzes knowledge sharing on biomedical HIV prevention interventions such as HIV vaccines, antibody infusions, pre-exposure prophylaxis, and microbicides in totality-from the molecular details and delivery formulations to the behavioral, social, and structural underpinnings. HIVR4P // Virtual was held over the course of 2 weeks on January 27-28 and February 3-4, 2021 as the coronavirus disease 2019 (COVID-19) pandemic continued to inflict unprecedented harm globally. The HIVR4P community came together with 1,802 researchers, care providers, policymakers, implementers, and advocates from 92 countries whose expertise spanned the breadth of the HIV prevention pipeline from preclinical to implementation. The program included 113 oral and 266 poster presentations. This article presents a brief summary of the conference highlights. Complete abstracts, webcasts, and daily rapporteur summaries may be found on the conference website (https://www.hivr4p.org/).

Keywords: HIV; HIVR4P; PrEP; South Africa; TaSP; antiretrovirals; broadly neutralizing antibodies (bNAbs); clinical trials; microbicides; prevention; vaccine.

PubMed Disclaimer

Conflict of interest statement

No competing financial interests exist.

References

    1. UNAIDS: Data 2020. 30 pp, 2020. Available at https://www.unaids.org/sites/default/files/media_asset/2020_aids-data-bo..., accessed July 5, 2021.
    1. Wang C, Wang Z, Wang G, et al. : COVID-19 in early 2021: Current status and looking forward. Signal Transduct Target Ther 2021;6:114. - PMC - PubMed
    1. UNAIDS: Preliminary UNAIDS 2021 epidemiological estimates. 3 pp, 2021. Available at https://embargo.unaids.org/static/files/uploaded_files/UNAIDS_2021_FactS..., accessed July 1, 2021.
    1. Graham BS, Gilman MSA, McLellan JS. Structure-based vaccine antigen design. Annu Rev Med 2019;70:91–104. - PMC - PubMed
    1. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, et al. : Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009;361:2209–2220. - PubMed

Publication types

MeSH terms